|
|
|
|
Vol. 54, Issue 5, 918-927, November 1998
-Aminobutyric
Acid-Modulatory Activity
Department of Anesthesiology (S.M.T., M.P., Y.M.N.,C.J.L.),
Department of Molecular Biology and Pharmacology (K.R.N., M.H.,
D.F.C.), and
Department of Psychiatry (C.F.Z.), Washington University
School of Medicine, St. Louis, Missouri 63110
A number of steroids seem to have anesthetic effects resulting
primarily from their ability to potentiate currents gated by
-aminobutyric acidA (GABAA) receptor
activation. One such compound is
(3
,5
,17
)-3-hydroxyandrostane-17-carbonitrile [(+)-ACN]. We
were interested in whether carbonitrile substitution at other ring
positions might result in other pharmacological consequences. Here we
examine effects of (3
,5
,17
)-17-hydroxyestrane-3-carbonitrile [(+)-ECN] on GABAA receptors and Ca2+
channels. In contrast to (+)-ACN, (+)-ECN does not potentiate GABAA-receptor activated currents, nor does it directly
gate GABAA-receptor mediated currents. However, both
steroids produce an enantioselective reduction of T-type current.
(+)-ECN blocked T current with an IC50 value of 0.3 µM with a maximal block of 41%. (+)-ACN produced a
partial block of T current (44% maximal block) with an
IC50 value of 0.4 µM. Block of T current
showed mild use- and voltage-dependence. The (
)-ECN enantiomer was
about 33 times less potent than (+)-ECN, with an IC50 value
of 10 µM and an amount of maximal block comparable to
(+)-ECN. (+)-ECN was less effective at blocking high-voltage-activated Ca2+ current in DRG neurons (IC50 value of 9.3 µM with maximal block of about 27%) and hippocampal
neurons. (+)-ECN (10 µM) had minimal effects on
voltage-gated sodium and potassium currents in rat chromaffin cells.
The results identify a steroid with no effects on GABAA
receptors that produces a partial inhibition of T-type Ca2+
current with reasonably high affinity and selectivity. Further study of
steroid actions on T currents may lead to even more selective and
potent agents.
This article has been cited by other articles:
![]() |
M. M. Jagodic, S. Pathirathna, P. M. Joksovic, W. Lee, M. T. Nelson, A. K. Naik, P. Su, V. Jevtovic-Todorovic, and S. M. Todorovic Upregulation of the T-Type Calcium Current in Small Rat Sensory Neurons After Chronic Constrictive Injury of the Sciatic Nerve J Neurophysiol, June 1, 2008; 99(6): 3151 - 3156. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, X. Jin, D. F. Covey, and J. H. Steinbach Neuroactive Steroids and Human Recombinant {rho}1 GABA Receptors J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 236 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, J. Bracamontes, B. W. Katona, D. F. Covey, J. H. Steinbach, and G. Akk Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat {alpha}1beta2{gamma}2L GABAA Receptor Mol. Pharmacol., June 1, 2007; 71(6): 1582 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Nelson, P. M. Joksovic, E. Perez-Reyes, and S. M. Todorovic The Endogenous Redox Agent L-Cysteine Induces T-Type Ca2+ Channel-Dependent Sensitization of a Novel Subpopulation of Rat Peripheral Nociceptors J. Neurosci., September 21, 2005; 25(38): 8766 - 8775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Todorovic, S. Pathirathna, B. C. Brimelow, M. M. Jagodic, S.-H. Ko, X. Jiang, K. R. Nilsson, C. F. Zorumski, D. F. Covey, and V. Jevtovic-Todorovic 5{beta}-Reduced Neuroactive Steroids Are Novel Voltage-Dependent Blockers of T-Type Ca2+ Channels in Rat Sensory Neurons in Vitro and Potent Peripheral Analgesics in Vivo Mol. Pharmacol., November 1, 2004; 66(5): 1223 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Todorovic, V. Jevtovic-Todorovic, S. Mennerick, E. Perez-Reyes, and C. F. Zorumski Cav3.2 Channel Is a Molecular Substrate for Inhibition of T-Type Calcium Currents in Rat Sensory Neurons by Nitrous Oxide Mol. Pharmacol., September 1, 2001; 60(3): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Paradiso, K. Sabey, A. S. Evers, C. F. Zorumski, D. F. Covey, and J. H. Steinbach Steroid Inhibition of Rat Neuronal Nicotinic alpha 4beta 2 Receptors Expressed in HEK 293 Cells Mol. Pharmacol., August 1, 2000; 58(2): 341 - 351. [Abstract] [Full Text] |
||||